Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Concomitant use of statins and sodium‐glucose co‐transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis
British journal of clinical pharmacology, 2023-08, Vol.89 (8), p.2430-2445
2023
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors
British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.431-439
2023
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta‐analysis of randomized controlled trials
British journal of clinical pharmacology, 2023-03, Vol.89 (3), p.956-966
2023
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Post‐marketing safety concerns with nirmatrelvir: A disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
British journal of clinical pharmacology, 2023-09, Vol.89 (9), p.2830-2842
2023
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database
British journal of clinical pharmacology, 2023-08
2023
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease
British journal of clinical pharmacology, 2021-07, Vol.87 (7), p.2830-2837
2021
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Disease‐modifying agents for multiple sclerosis and the risk for reporting cancer: A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database
British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4769-4779
2021
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Movement disorders associated with antiseizure medications: A real-world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System
British journal of clinical pharmacology, 2023-11, Vol.89 (11), p.3389-3400
2023
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database
British journal of clinical pharmacology, 2022-11, Vol.88 (11), p.4937-4940
2022
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Letter to the editor concerning the article: ‘Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA adverse event reporting system (FAERS)’
British journal of clinical pharmacology, 2023-08, Vol.89 (8), p.2639-2641
2023
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Ocular disorders associated with PCSK9 inhibitors: A pharmacovigilance disproportionality analysis
British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.458-469
2023
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
British journal of clinical pharmacology, 2011-12, Vol.72 (6), p.905-908
2011
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS)
British journal of clinical pharmacology, 2023-08, Vol.89 (8), p.2386-2395
2023
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis
British journal of clinical pharmacology, 2022-12, Vol.88 (12), p.5227-5237
2022
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to action
British journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3535-3536
2022
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase
British journal of clinical pharmacology, 2018-10, Vol.84 (10), p.2373-2383
2018
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis
British journal of clinical pharmacology, 2021-10, Vol.87 (10), p.3971-3977
2021
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase
British journal of clinical pharmacology, 2020-05, Vol.86 (5), p.991-998
2020
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: case reports and disproportionality analyses in Vigibase(R): Br J Clin Pharmacol
British journal of clinical pharmacology, 2020, Vol.86 (5), p.991-998
2020
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Thromboembolic events in Janus kinase inhibitors: A pharmacovigilance study from 2012 to 2021 based on the Food and Drug Administration's Adverse Event Reporting System
British journal of clinical pharmacology, 2022-09, Vol.88 (9), p.4180-4190
2022
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Considerations on the use of different comparators in pharmacovigilance: A methodological review
British journal of clinical pharmacology, 2023-09, Vol.89 (9), p.2671-2676
2023
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Adverse event profiles of PCSK9 inhibitors alirocumab and evolocumab: Data mining of the FDA adverse event reporting system
British journal of clinical pharmacology, 2022-12, Vol.88 (12), p.5317-5325
2022
Link zum Volltext
Verfügbarkeit prüfen
Open Access
    Datensatz exportieren als...
  • BibTeX
Retroperitoneal fibrosis and β‐blocking agents: Is there an association?
British journal of clinical pharmacology, 2021-07, Vol.87 (7), p.2891-2901
2021
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Abuse and misuse of second‐generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database
British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4646-4653
2022
Link zum Volltext
Verfügbarkeit prüfen
    Datensatz exportieren als...
  • BibTeX
Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database
British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.865-873
2023
Link zum Volltext
Verfügbarkeit prüfen
1 – 25 von 109
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieBritish Journal Of Clinical Pharmacology
Suchergebnisse filtern
Filter anzeigen